INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 101 filers reported holding INHIBRX INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,843,032 | -28.6% | 1,789,811 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $45,989,178 | +37.3% | 1,771,540 | -0.2% | 0.00% | 0.0% |
| Q1 2023 | $33,499,553 | -22.8% | 1,775,281 | +0.8% | 0.00% | 0.0% |
| Q4 2022 | $43,375,591 | +64.6% | 1,760,373 | +19.9% | 0.00% | 0.0% |
| Q3 2022 | $26,348,000 | +71.2% | 1,467,918 | +8.2% | 0.00% | – |
| Q2 2022 | $15,391,000 | -43.3% | 1,356,116 | +11.3% | 0.00% | -100.0% |
| Q1 2022 | $27,140,000 | -48.5% | 1,218,113 | +0.9% | 0.00% | 0.0% |
| Q4 2021 | $52,699,000 | +132.8% | 1,206,748 | +77.6% | 0.00% | 0.0% |
| Q3 2021 | $22,636,000 | +66.2% | 679,525 | +37.3% | 0.00% | – |
| Q2 2021 | $13,618,000 | +75.4% | 494,849 | +27.9% | 0.00% | – |
| Q1 2021 | $7,764,000 | -38.2% | 386,892 | +1.6% | 0.00% | – |
| Q4 2020 | $12,557,000 | +2225.4% | 380,849 | +1169.5% | 0.00% | – |
| Q3 2020 | $540,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |